相似文献
1
Old medications and new targeted therapies in systemic sclerosis.
Rheumatology (Oxford). 2015 Nov;54(11):1944-53. doi: 10.1093/rheumatology/keu285. Epub 2014 Jul 26.
2
Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
Rheum Dis Clin North Am. 2003 May;29(2):409-26. doi: 10.1016/s0889-857x(03)00026-7.
3
Vascular complications of scleroderma.
Autoimmun Rev. 2007 Sep;6(8):520-3. doi: 10.1016/j.autrev.2006.12.006. Epub 2007 Jan 12.
4
[Systemic sclerosis].
Rev Prat. 2017 Sep;67(7):775-783.
5
2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis.
Adv Rheumatol. 2024 Jul 10;64(1):52. doi: 10.1186/s42358-024-00392-w.
6
Is there evidence for vasculitis in systemic sclerosis?
Curr Rheumatol Rep. 2012 Dec;14(6):516-25. doi: 10.1007/s11926-012-0296-9.
7
Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
Rheumatol Int. 2013 Apr;33(4):1047-52. doi: 10.1007/s00296-012-2466-5. Epub 2012 Jul 26.
8
Treatment of systemic sclerosis.
Am J Clin Dermatol. 2001;2(5):315-25. doi: 10.2165/00128071-200102050-00006.
9
Treatment Algorithms for Systemic Sclerosis According to Experts.
Arthritis Rheumatol. 2018 Nov;70(11):1820-1828. doi: 10.1002/art.40560. Epub 2018 Sep 17.
10
[Systemic sclerosis].
Med Monatsschr Pharm. 2008 May;31(5):162-70; quiz 171-2.
引用本文的文献
1
Efficacy of cyclophosphamide for skin fibrosis in systemic sclerosis: a systematic review and single-arm meta-analysis.
Eur J Clin Pharmacol. 2025 Jun;81(6):863-874. doi: 10.1007/s00228-025-03837-3. Epub 2025 Apr 8.
2
Stem cell transplantation for systemic sclerosis.
Cochrane Database Syst Rev. 2022 Jul 29;7(7):CD011819. doi: 10.1002/14651858.CD011819.pub2.
3
[Expression of pituitary tumor-transforming gene-1 and its pathogenic role in systemic sclerosis].
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Nov 30;40(11):1564-1570. doi: 10.12122/j.issn.1673-4254.2020.11.05.
4
Evolution of Systemic Sclerosis-Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide.
Arthritis Care Res (Hoboken). 2022 Mar;74(3):433-441. doi: 10.1002/acr.24451. Epub 2022 Jan 13.
5
The efficacy and safety of fecal microbiota transplantation in the treatment of systemic sclerosis: A protocol for systematic review and meta analysis.
Medicine (Baltimore). 2020 Jul 10;99(28):e21267. doi: 10.1097/MD.0000000000021267.
6
IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases.
Int J Mol Sci. 2019 Nov 22;20(23):5856. doi: 10.3390/ijms20235856.
7
Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.
Arthritis Res Ther. 2019 Oct 15;21(1):212. doi: 10.1186/s13075-019-1991-y.
8
Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Front Immunol. 2018 Oct 16;9:2390. doi: 10.3389/fimmu.2018.02390. eCollection 2018.
9
Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitis.
Eur J Rheumatol. 2018 Dec;5(4):269-271. doi: 10.5152/eurjrheum.2018.17177. Epub 2018 Jun 20.
10
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.
Arthritis Rheumatol. 2018 Feb;70(2):308-316. doi: 10.1002/art.40358. Epub 2017 Dec 29.
本文引用的文献
1
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368.
2
Treatment goals of pulmonary hypertension.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D73-81. doi: 10.1016/j.jacc.2013.10.034.
3
Updated treatment algorithm of pulmonary arterial hypertension.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D60-72. doi: 10.1016/j.jacc.2013.10.031.
4
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs.
Nat Med. 2013 Dec;19(12):1617-24. doi: 10.1038/nm.3282. Epub 2013 Nov 10.
5
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients.
Oncoimmunology. 2013 Aug 1;2(8):e26218. doi: 10.4161/onci.26218. Epub 2013 Aug 27.
6
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.
Semin Arthritis Rheum. 2014 Apr;43(5):666-72. doi: 10.1016/j.semarthrit.2013.09.008. Epub 2013 Oct 7.
7
Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.
Ann Rheum Dis. 2014 Jan;73(1):56-61. doi: 10.1136/annrheumdis-2013-203674. Epub 2013 Sep 25.
8
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
Arthritis Rheum. 2013 Dec;65(12):3194-201. doi: 10.1002/art.38172.
9
Efficacy of the specific endothelin a receptor antagonist zibotentan (ZD4054) in colorectal cancer: a preclinical study.
Mol Cancer Ther. 2013 Aug;12(8):1556-67. doi: 10.1158/1535-7163.MCT-12-0975. Epub 2013 May 30.
10
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.
QJM. 2013 Sep;106(9):839-48. doi: 10.1093/qjmed/hct111. Epub 2013 May 21.
Zotero 插件